Clinical Trials
19 trialsNCT07169851 2026-06-04
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
NCT07582887 2026-05-13
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Recruiting
NCT04659343 2026-05-04
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
Recruiting
NCT05838638 2026-05-01
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
University of Central Florida
Phase NA Recruiting
NCT07354971 2026-04-28
IMMUNO-FIT Observational Study
University Hospital Southampton NHS Foundation Trust
Recruiting
NCT07524829 2026-04-13
Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients
Azienda Sanitaria Locale di Asti
Phase NA Recruiting
NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
NCT05512169 2026-01-15
MPGx-INDALL
University of Geneva, Switzerland
Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT06726590 2025-09-12
IPGx Registry
Texas A&M University
Recruiting
NCT06789601 2025-06-19
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Brigham and Women's Hospital
Phase 1/2 Recruiting
NCT06716619 2025-03-26
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT05652673 2025-02-28
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Erasmus Medical Center
Phase NA Recruiting
NCT06302062 2024-12-03
TAL-T
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT04696081 2024-08-09
AFIB-CANCER
University Hospital, Caen
Recruiting
NCT05717699 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT05717712 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT05800054 2023-04-05
Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting